Krsnaa Diagnostics Limited (KRSNAA) - Total Liabilities

Latest as of September 2025: Rs5.84 Billion INR ≈ $63.13 Million USD

Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has total liabilities worth Rs5.84 Billion INR (≈ $63.13 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Krsnaa Diagnostics Limited (KRSNAA) asset resilience to evaluate the company's liquid asset resilience ratio.

Krsnaa Diagnostics Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Krsnaa Diagnostics Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Krsnaa Diagnostics Limited assets under control.

Krsnaa Diagnostics Limited Competitors by Total Liabilities

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Sentral REIT KLSE:5123	Malaysia	RM1.31 Billion
Exicon Co. Ltd KQ:092870	Korea	₩35.14 Billion
Indeks Bilgisayar Sistemleri Muhendislik Sanayi ve Ticaret AS IS:INDES	Turkey	TL25.32 Billion
Anika Therapeutics Inc NASDAQ:ANIK	USA	$45.49 Million
Nampak JSE:NPK	South Africa	ZAC8.19 Billion
Legal & General Group PLC LSE:LGEN	UK	GBX610.73 Billion
Toro Ltd NASDAQ:TORO	USA	$4.05 Million
Taigen Biopharmaceuticals Holdings Ltd TWO:4157	Taiwan	NT$61.95 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Krsnaa Diagnostics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See KRSNAA equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.63	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.39	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Krsnaa Diagnostics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual total liabilities of Krsnaa Diagnostics Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs3.99 Billion ≈ $43.13 Million	+10.14%
2024-03-31	Rs3.62 Billion ≈ $39.16 Million	+111.57%
2023-03-31	Rs1.71 Billion ≈ $18.51 Million	-17.49%
2022-03-31	Rs2.07 Billion ≈ $22.43 Million	-44.34%
2021-03-31	Rs3.73 Billion ≈ $40.30 Million	-54.94%
2020-03-31	Rs8.27 Billion ≈ $89.43 Million	+34.70%
2019-03-31	Rs6.14 Billion ≈ $66.39 Million	+93.54%
2018-03-31	Rs3.17 Billion ≈ $34.30 Million	+217.46%
2017-03-31	Rs999.19 Million ≈ $10.81 Million	--

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research

Market Cap

$196.45 Million

Rs18.17 Billion INR

Market Cap Rank

#16744 Global

#868 in India

Share Price

Rs560.00

Change (1 day)

+1.64%

52-Week Range

Rs520.30 - Rs866.20

All Time High

Rs1020.15